Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

4 big analyst picks: Adobe nabs another buy rating on AI

Published 06/22/2023, 05:31 AM
© Reuters

Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades at Adobe, Shell, Grab, and XP.

InvestingPro subscribers got this news first. Never miss another market-moving headline.

Adobe upgraded to Outperform

Adobe Systems (NASDAQ:ADBE) was upgraded to Outperform from Market Perform at BMO Capital with a price target of $570.00 (from $500.00).

The firm is particularly positive on Adobe's generative AI product, Firefly, the initial beta release of which has attracted substantial interest from millions of users. BMO said it believes Firefly "can capture price/mix, as well as new users." It added that upside looks to be in the cards:

Although the stock has moved higher over the past few months, we nevertheless believe that upside to the stock remains, particularly when compared with other large cap growth stocks.

Furthermore, BMO says positive feedback from its survey on the Adobe Express product suggests that new annual recurring revenue can remain around $1.8 billion through fiscal 2024.

Wells Fargo also upgraded Adobe earlier this month on its AI potential.

And last week the company beat on Q2 earnings, with EPS of $3.91 and revenue of $4.82 billion coming in better than Wall Street expectations.

Shell upgraded at Morgan Stanley

Morgan Stanley upgraded Shell (NYSE:SHEL) to Equalweight from Underweight. Initially, the bank anticipated that a decrease in the quarterly buyback rate would lead to a period of underperformance. “Although buybacks are indeed guided to be lower in 2H than 1H, other parts of Shell's investment thesis surprised positively at the recent CMD,” said the firm.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company is set to report its Q2/23 earnings next month. Street estimates stand at $1.86 for EPS and $72.09B for revenues.

2 more upgrades

JPMorgan upgraded Grab Holdings (NASDAQ:GRAB) to Neutral from Underweight with a price target of $3.10.

BofA Securities upgraded XP (NASDAQ:XP) to Buy from Neutral and raised its price target to $29.00 from $16.00.

Amid an endless firehose of market headlines, jump on the most important ones to fatten your profits: Always be the first to know with InvestingPro.

Summer Sale Is Live!

Latest comments

Kidneys are organs in the abdomen that aids in maintaining the balance of chemicals in the body by eliminating waste and excess fluid from blood in the form of urine and by eliminating excessive salt as well as calcium, potassium, and sodium. The renals also make hormones that regulate blood pressure and also encourage the creation of red blood cells in the bone marrow. A sudden and often reversed decrease in the function of the kidney, assessed by the glomerular filter rate (GFR), is referred to as acute kidney injury (AKI), which was previously called acute renal failure (ARF). The reduction in the flow of urine could be the only sign of acute damage to the kidneys. AKI can result in the accumulation of salt, water and various metabolic byproducts. Furthermore, it may result in the development of a number of electrolyte issues, particularly for those who are in hospitals, as it is an extremely common condition.
yes
Adobe upgraded with anticipation of new users..... ..so was every Adobe's competitors.....kind of wonder where all these sudden influx of new users come from when all existing users didn't switch to others
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.